3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
3
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
2
Waldenstrom Macroglobulinemia
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Burkitt Lymphoma
1
Interventions
Rituximab
16
Cyclophosphamide
16
Prednisone
7
Doxorubicin
7
pirtobrutinib
6
fludarabine
6
Vincristine
6
Lenalidomide
6
venetoclax
5
pembrolizumab
5
fludarabine phosphate
5
Etoposide
5
Bendamustine Hydrochloride
5
ibrutinib
4
acalabrutinib
4
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Dexamethasone
4
CT-P10
4
polatuzumab vedotin
3
etoposide phosphate
3
Immunotherapy, Adoptive
3
tazemetostat
2
liposomal doxorubicin
2
Nivolumab
2
Injections
2
Ifosfamide
2
Gemcitabine
2
Cisplatin
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphoma, B-Cell
×
loncastuximab tesirine
×
Clear all
NCT05270057
2025-10-09
LONCA
Medical College of Wisconsin
Phase 1
Active not recruiting
11 enrolled